LOCAL SCHEME, VOCAL DEBATE
Business Standard|November 06, 2024
Detractors say schemes like MPLAD seriously erode the notion of separation of powers as the legislator directly becomes the executive while implementing them
SHIVA RAJORA
LOCAL SCHEME, VOCAL DEBATE

One year after it was launched, the performance of the Member of Parliament Local Area Development Scheme (MPLADS), schemes that state assemblies and panchayats advocate for their elected representatives, is contested.

Critics of these schemes argue that they erode the fundamental principle of separation of powers between the legislature and the executive, and are a mechanism to facilitate the distribution of public funds.

Supporters of these schemes, primarily elected representatives, argue that the schemes allow them to direct funds according to the needs of their constituents.

Critics say such schemes are misconceived. They violate the constitutional spirit of separation of powers between the legislature and the executive.

Jagdeep Chhokar, founder of the Association for Democratic Reforms, says that these schemes lead to the devaluation of the legislative process.

He points out that there are rarely any audits and probes into the utilization of public funds under these schemes, and that they are mostly used to settle political scores around election time.

On Monday, according to media reports, Lok Sabha member Agatha Sangma from Tura, Meghalaya, reportedly said that a review committee at the state level found that the projects undertaken under the scheme in her constituency were incomplete.

Sangma said that 20 years is not a short time, and that projects have been pending since 2002. "I don't want to comment at the moment, but the delays might be due to wrong choices made by my predecessors," Sangma said.

When Business Standard contacted Saleng by phone on Tuesday, he described his flagging of irregularities in the MPLAD scheme in Tura as a "small matter" involving "meagre amounts," which should not detract from the importance of MPLAD. He said that the annual allocation of ₹5 crore to MPs under MPLAD was fixed a decade ago and needs to be increased.

この記事は Business Standard の November 06, 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Business Standard の November 06, 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

BUSINESS STANDARDのその他の記事すべて表示
Technology changes BFSI sector
Business Standard

Technology changes BFSI sector

Firms in the industry are undergoing a major digital transformation, with technologies - Cloud, Al, GenAI, RPA, and blockchain - leading the way, says a Business Standard-Everest Group report

time-read
7 分  |
November 06, 2024
Making sense of India's real estate boom
Business Standard

Making sense of India's real estate boom

Growth drivers in real estate include urbanisation, disposable incomes, and demand for residential, commercial, and logistics spaces, according to a Business Standard-Knight Frank report

time-read
8 分  |
November 06, 2024
Business Standard

THE BIGGEST BFSI SUMMIT IS EVEN BIGGER NOW

The largest financial sector event in the country - the Business Standard BFSI Insight Summit - is back this year in a bigger form.

time-read
3 分  |
November 06, 2024
Shares of Adani Ports anchor at 5-month low
Business Standard

Shares of Adani Ports anchor at 5-month low

Down 5% in two days after business update for October

time-read
2 分  |
November 06, 2024
Business Standard

Markets rebound as investors cast wide net for value

In-demand financial stocks drive the rally

time-read
2 分  |
November 06, 2024
Business Standard

Global mkt: Stocks, Treasury yields gain as US votes

World stocks rose and Treasury yields rebounded on Tuesday while an index of market volatility retreated, as markets awaited early indications of the outcome of a knife-edge US election, with only currency markets showing some jitters.

time-read
1 min  |
November 06, 2024
Business Standard

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma's Q2FY25 results beat muted expectations, with upper-teens EPS growth projected over the next two financial years despite a slowdown in US sales and temporary issues at its Cenexi subsidiary.

time-read
2 分  |
November 06, 2024
Sagility India IPO booked 22% on Day 1
Business Standard

Sagility India IPO booked 22% on Day 1

The initial public offering (IPO) of Sagility India Ltd, a technology-enabled services provider in the health care space, received 22 per cent subscription on the first day of bidding on Tuesday.

time-read
1 min  |
November 06, 2024
Record FPI exodus throws a shadow on stock markets
Business Standard

Record FPI exodus throws a shadow on stock markets

Foreign investors are souring on India's stock market, selling a record amount of shares amid signs the South Asian nation's post-pandemic economic boom is losing steam.

time-read
1 min  |
November 06, 2024
Govt may divest 2.5% in HZL through OFS
Business Standard

Govt may divest 2.5% in HZL through OFS

The Centre is planning to sell 2.5 per cent of the total share capital of Hindustan Zinc Ltd (HZL) through an offer for sale (OFS) on Wednesday and Thursday for ₹505 per share.

time-read
1 min  |
November 06, 2024